Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer. (Record no. 28361964)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01964 a2200589 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517214026.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201902s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1878-3686 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.ccell.2018.04.001 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Hellmann, Matthew D |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190227 |
| 245 00 - TITLE STATEMENT | |
| Title | Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer cell |
| Date of publication, distribution, etc. | 05 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 853-861.e4 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ipilimumab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lung Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nivolumab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Small Cell Lung Carcinoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tumor Burden |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Exome Sequencing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Callahan, Margaret K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Awad, Mark M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Calvo, Emiliano |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ascierto, Paolo A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Atmaca, Akin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rizvi, Naiyer A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hirsch, Fred R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Selvaggi, Giovanni |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Szustakowski, Joseph D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sasson, Ariella |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Golhar, Ryan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vitazka, Patrik |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chang, Han |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Geese, William J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Antonia, Scott J |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer cell |
| Related parts | vol. 33 |
| -- | no. 5 |
| -- | p. 853-861.e4 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.ccell.2018.04.001">https://doi.org/10.1016/j.ccell.2018.04.001</a> |
| Public note | Available from publisher's website |
No items available.